Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study

<div>In-hospital mortality of critically ill patients with MRSA bacteremia treated with vancomycin according accessory gene regulator (<i>agr</i>) polymorphism. Values expressed as deaths/survival cases.</div>

Canadian Journal of Infectious Diseases and Medical Microbiology

fig2

Figure 2

Figure 2: Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study 

Figure 2 | Association between Accessory Gene Regulator Polymorphism and Mortality among Critically Ill Patients Receiving Vancomycin for Nosocomial MRSA Bacteremia: A Cohort Study 